article thumbnail

Deliberate AI Announces its Depression and Anxiety Model, AI-COA™, is the First AI/ML Initiative to Be Accepted into the FDA’s ISTAND Pilot Program to Advance Drug Development

Digital Health Global

NEW YORK–(BUSINESS WIRE)– Deliberate AI , a digital health technology company that delivers precision measurement of mental health through AI, today announced its inclusion in the U.S. Food and Drug Administration (FDA) Innovative Science and Technology Approaches for New Drugs (ISTAND) Pilot Program.

article thumbnail

Digital Health Technologies in Clinical Trials

Digital Health Global

Digital Health Technologies ( DHTs ) have revolutionized the landscape of clinical trials, particularly in neurology research, by enabling the collection of real-world data outside traditional clinical settings.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The outlook for healthcare in 2022

Waracle

Whether it is in operational delivery, service provision, patient enablement or drug discovery, technology has continued to create wide scale impact as we shift towards a post-pandemic world. But that is something that AR and VR technology have the potential to enhance in the future.

article thumbnail

Blockchain in Healthcare: A Vehicle Towards Digital Health 2.0?

The Digital Health Corner

Interestingly, an IBM survey of 200 healthcare executives in 16 countries focused on interest in adopting blockchain technology revealed that this is a very rapidly evolving area. One of the most obvious benefits of blockchain resides in improving privacy of electronic health records.